The Agriculture Biotechnology Market has emerged as a dynamic and transformative sector within the global agriculture industry. Leveraging cutting-edge genetic and molecular techniques, this market aims to enhance crop yields, improve resistance to pests and diseases, and create sustainable agricultural solutions. With a growing global population and increasing environmental challenges, agriculture biotechnology plays a pivotal role in ensuring food security and sustainability for the future.

The report “Agriculture Biotechnology Market, By Type (Molecular Diagnostics, Molecular Markers, Tissue Culture, Vaccines, and Genetic Engineering), By Application (Transgenic Crops and Synthetic Biology-Enabled Products), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Highlights:

  • In June 2023, Godrej Agrovet (GAVL)’s Crop Protection Business today announced that its bio-stimulant, Double, has completed 25 years of enabling better yield for Indian farmers. Over the past 25 years, the crop protection company stated that Double had treated three crore acres of Indian agriculture and improved the lives of two crore farming families. Additionally, the company unveiled a commemorative pack to honour Double's 25 years in business and its commitment to better farming as well as safeguarding farmers against imitation goods.
  • In July 2023, The Bill & Melinda Gates Foundation, Innovation Industries, Korys Investments, and BNP Paribas Fortis are among the investors who contributed to Aphea.Bio's €70 million Series C funding round. Aphea.Bio is a Belgian agricultural biotech firm that creates pesticide substitutes to increase crop growth. Additionally, previous investors ECBF and Astanor contributed.

Analyst View:

Analysts view the agriculture biotechnology market as a critical driver of innovation in agriculture, offering substantial potential for increased productivity and sustainability. They highlight its ability to address food security challenges, reduce the environmental impact of farming, and adapt crops to changing climate conditions. Moreover, the market is expected to witness significant growth driven by ongoing advancements in genetic engineering and increasing adoption of biotechnological solutions by farmers and the agricultural industry as a whole.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

Key Market Insights from the report:

Agriculture Biotechnology Market accounted for US$ 101.3 billion in 2022 and is estimated to be US$ 253.6 billion by 2032 and is anticipated to register a CAGR of 9.0%. Agriculture Biotechnology Market is segmented based on Type, Application and Region.

  • Based on Type, Agriculture Biotechnology Market is segmented into Molecular Diagnostics, Molecular Markers, Tissue Culture, Vaccines, and Genetic Engineering.
  • Based on Application, Agriculture Biotechnology Market is segmented into Transgenic Crops and Synthetic Biology-Enabled Products.
  • By Region, the Agriculture Biotechnology Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Agriculture Biotechnology Market:

The prominent players operating in the Agriculture Biotechnology Market includes, Pfizer, Inc., Roche, Inc., Sanofi, Inc., Johnson & Johnson, Merck & Co. (MSD), Novartis AG, AbbVie, Inc., Gilead Sciences, GlaxoSmithKline (GSK), Amgen and others.

To know more

Contact Us:


Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]